Shuttle Pharmaceuticals Holdings, Inc.
General ticker "SHPH" information:
- Sector: Health Care
- Industry: Drug Manufacturers - Specialty & Generic
- Capitalization: $4.2M (TTM average)
Shuttle Pharmaceuticals Holdings, Inc. does not follow the US Stock Market performance with the rate: -35.2%.
Estimated limits based on current volatility of 5.3%: low 5.04$, high 5.51$
Factors to consider:
- Total employees count: 2 (-77.8%) as of 2025
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Economic downturns and volatility, Inability to raise capital, Acquisition/divestiture risks, Internal control weaknesses, IT system disruptions
- Current price 35.8% below estimated low
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [8.08$, 35.20$]
- 2026-12-31 to 2027-12-31 estimated range: [3.84$, 17.92$]
Financial Metrics affecting the SHPH estimates:
- Negative: with PPE of -0.7 at the end of fiscal year the price was very high
- Negative: negative Operating income
- Negative: negative Net income
- Negative: negative Operating cash flow
- Negative: Industry operating cash flow per share per price (median), % of -0.61 <= 0.01
- Negative: 12.29 < Shareholder equity ratio, % of 21.52 <= 24.07
- Negative: Investing cash flow per share per price, % of -104.09 <= -39.19
- Negative: negative Industry operating income (median)
- Negative: 0.43 < Industry inventory ratio change (median), % of 0.97
Short-term SHPH quotes
Long-term SHPH plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $5.89MM | $7.70MM | $11.92MM |
| Operating Income | $-5.89MM | $-7.70MM | $-11.92MM |
| Non-Operating Income | $-0.70MM | $-1.45MM | $0.20MM |
| Interest Expense | $2.49MM | $1.21MM | $0.07MM |
| R&D Expense | $3.52MM | $3.62MM | $4.05MM |
| Income(Loss) | $-6.59MM | $-9.14MM | $-11.72MM |
| Net Income(Loss)* | $-6.59MM | $-9.14MM | $-11.72MM |
| Stockholders Equity | $4.06MM | $0.71MM | $2.25MM |
| Assets | $5.95MM | $2.51MM | $10.48MM |
| Operating Cash Flow | $-5.58MM | $-7.33MM | $-9.48MM |
| Capital expenditure | $0.02MM | $0.00MM | $0.00MM |
| Investing Cash Flow | $-2.83MM | $2.92MM | $-3.06MM |
| Financing Cash Flow | $2.57MM | $3.76MM | $10.95MM |
| Earnings Per Share** | $-4.14 | $-8.86 | $-71.56 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.